纳入研究 | 样本量(例) | 性别(男/女) | 平均年龄(岁) | 干预措施 | 疗程(d) | 结局指标 | ||||
T | C | T | C | T | C | T | C | |||
李健洪,2019 | 50 | 50 | 31/19 | 33/17 | 56.81 ± 7.16 | 56.95 ± 7.34 | 稳心颗粒 + 常规西药 | 常规西药 | 180 | ①② |
张雨虹,2014 | 40 | 46 | - | - | 52.4 ± 6.4 | 61.24 ± 15.18 | 稳心颗粒 + 常规西药 | 常规西药 | 365 | ①② |
武宗义,2010 | 57 | 53 | 32/25 | 31/22 | 71.4 ± 4.5 | 69.8 ± 4.3 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ①② |
张强,2020 | 59 | 59 | 34/25 | 32/27 | 58.2 ± 4.7 | 57.8 ± 4.5 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ①② |
陆宏伟,2014 | 90 | 90 | 48/42 | 46/44 | 60.2 ± 6.9 | 61.8 ± 7.2 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ①② |
刘世宏,2019 | 55 | 55 | 33/22 | 35/20 | 60.45 ± 8.64 | 61.02 ± 8.42 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ① |
张扬,2018 | 60 | 60 | 33/27 | 31/29 | 61.3 ± 5.5 | 62.4 ± 6.4 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ① |
田丰,2017 | 58 | 58 | 40/18 | 39/19 | 61.16 ± 6.34 | 61.02 ± 6.31 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ①② |
李大军,2020 | 43 | 43 | 29/14 | 30/13 | 61.7 ± 6.9 | 62.5 ± 6.5 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ① |
姚福梅,2006 | 38 | 38 | 44/32 | 56.6 ± 10.9 | 50.1 ± 12.4 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ① | |
韩志翔,2018 | 34 | 34 | 21/13 | 22/12 | 59.28 ± 6.46 | 59.41 ± 6.59 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ① |
任保军,2009 | 100 | 100 | 58/32 | 70/30 | 64 ± 3.7 | 65 ± 4.1 | 通心络胶囊 + 常规西药 | 常规西药 | - | ①② |
肖红兵,2007 | 62 | 70 | 42/20 | 49/21 | 53 ± 12 | 55 ± 10 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ①② |
王新冬,2010 | 68 | 64 | 43/25 | 45/19 | 65.2 ± 9.9 | 65.1 ± 10.4 | 通心络胶囊 + 常规西药 | 常规西药 | 180~365 | ①② |
孙智睿,2018 | 67 | 67 | 44/23 | 46/21 | 62.72 ± 3.1 | 60.84 ± 7.8 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ① |
梁燕敏,2010 | 42 | 38 | 52/28 | 40~70,平均年龄55 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ①② | ||
王艳红,2009 | 40 | 40 | 28/12 | 26/14 | 54.2 ± 10.2 | 52.5 ± 11.0 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ①② |
代国方,2011 | 31 | 30 | 19/12 | 17/13 | 61.3 ± 7.23 | 63.5 ± 6.1 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ① |
邓贤达,2013 | 31 | 30 | 21/10 | 20/10 | 42~76,平均年龄59 | 41~78,平均年龄59.5 | 通心络胶囊 + 常规西药 | 常规西药 | 180 | ① |
汤妍,2015 | 44 | 44 | 29/15 | 31/13 | 53.6 ± 2.4 /53.0 ± 2.2 | 57.12 ± 7.38 | 复方丹参滴丸 + 常规西药 | 常规西药 | 180 | ① |
毛向群,2014 | 70 | 70 | 46/24 | 44/26 | 65.4 ± 5.5 | 66.6 ± 5.8 | 复方丹参滴丸 + 常规西药 | 常规西药 | 365 | ① |
李献良,2022 | 31 | 31 | 21/10 | 20/11 | 60.88 ± 8.93 | 61.47 ± 7.71 | 复方丹参滴丸 + 常规西药 | 常规西药 | 180 | ①② |
成玲,2019 | 64 | 61 | 38/26 | 37/24 | 63.42 ± 7.69 | 62.18 ± 7.35 | 芪参益气滴丸 + 常规西药 | 常规西药 | 180 | ①② |
王慧,2013 | 50 | 50 | 28/22 | 23/27 | 60.78 ± 8.92 | 60.64 ± 9.49 | 芪参益气滴丸 + 常规西药 | 常规西药 | 180 | ①② |
陈要起,2018 | 77 | 76 | 52/25 | 51/25 | 62.4 ± 12.2 | 61.2 ± 12.4 | 芪苈强心胶囊 + 常规西药 | 常规西药 | 365 | ① |
司新成,2013 | 60 | 60 | 72/58 | 50.13 ± 11.27 | 麝香保心丸 + 常规西药 | 常规西药 | 545 | ①② | ||
张建刚,2021 | 50 | 50 | 28/22 | 30/20 | 58.46 ± 9.25 | 59.36 ± 10.34 | 麝香保心丸 + 常规西药 | 常规西药 | 365 | ① |
车贤达,2008 | 95 | 81 | 112/64 | 57 ± 8.7 | 麝香保心丸 + 常规西药 | 常规西药 | 180 | ① |